Algert Global’s Zymeworks ZYME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-423,646
Closed -$11.2M 1363
2025
Q4
$11.2M Buy
423,646
+215,720
+104% +$4.71M 0.17% 163
2025
Q3
$3.55M Buy
207,926
+89,822
+76% +$1.29M 0.06% 512
2025
Q2
$1.48M Buy
+118,104
New +$1.41M 0.03% 718
2022
Q2
Sell
-82,815
Closed -$542K 1412
2022
Q1
$542K Buy
82,815
+61,265
+284% +$546K 0.04% 780
2021
Q4
$353K Buy
21,550
+9,350
+77% +$195K 0.04% 671
2021
Q3
$354K Buy
+12,200
New +$406K 0.05% 693

Other funds holding ZYME

Algert Global's ZYME Position: Q1 2026 in Review

Algert Global sold out of Zymeworks (ZYME) in Q1 2026, closing a stake of 423,646 shares — an estimated $11.2M sold.

Algert Global first reported a position in ZYME in Q3 2021 and held it in 6 quarters. The position peaked at $11.2M in Q4 2025. 211 funds tracked by Wall St. Rank hold ZYME as of Q1 2026.

  • Algert Global reported no remaining Zymeworks position as of Q1 2026 after selling out during the quarter.
  • Algert Global sold 423,646 Zymeworks shares in Q1 2026, an estimated $11.2M.
  • Algert Global first reported a position in Zymeworks in Q3 2021 and held it in 6 quarters.
  • Algert Global's Zymeworks position peaked at $11.2M in Q4 2025.
  • 211 funds tracked by Wall St. Rank held Zymeworks as of Q1 2026.

Based on Algert Global's 13F filing for Q1 2026, filed 14 May 2026.